Overview

Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia

Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to find a way to predict how individual schizophrenic patients will respond if they are treated with different types of antipsychotic drugs. This could help doctors prescribe the medication that will work best for each individual.
Phase:
Phase 4
Details
Lead Sponsor:
Kettering Health Network
Treatments:
Aripiprazole
Risperidone